Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | PE(40:6e)/PE(40:5p) | Lipid-depleted/compactin | 0.0 | BCD100624C002 | 213 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | Lipid-depleted/compactin | 0.5 | BCD100624C005 | 143 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | Lipid-depleted/compactin | 1.0 | BCD100624C009 | 29.8 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | Lipid-depleted/compactin | 2.0 | BCD100624C013 | - | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | Lipid-depleted/compactin | 4.0 | BCD100624C017 | 194 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | Lipid-depleted/compactin | 8.0 | BCD100624C021 | 267 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | Lipid-depleted/compactin | 12.0 | BCD100624C025 | 84.4 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | Lipid-depleted/compactin | 24.0 | BCD100624C029 | 27.7 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | C | 0.0 | BCD100624C001 | 146 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | C | 0.5 | BCD100624C003 | 173 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | C | 1.0 | BCD100624C007 | 38 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | C | 2.0 | BCD100624C011 | 155 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | C | 4.0 | BCD100624C015 | 119 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | C | 8.0 | BCD100624C019 | 82.1 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | C | 12.0 | BCD100624C023 | 56.5 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | C | 24.0 | BCD100624C027 | 115 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100624C006 | 120 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100624C010 | - | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100624C014 | 182 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100624C018 | 73.4 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100624C022 | 62 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100624C026 | 44.8 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100624C030 | 24 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | 25OH-Chol | 0.5 | BCD100624C004 | 147 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | 25OH-Chol | 1.0 | BCD100624C008 | 70.6 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | 25OH-Chol | 2.0 | BCD100624C012 | 206 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | 25OH-Chol | 4.0 | BCD100624C016 | - | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | 25OH-Chol | 8.0 | BCD100624C020 | 149 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | 25OH-Chol | 12.0 | BCD100624C024 | 19.7 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | 25OH-Chol | 24.0 | BCD100624C028 | 82.9 | pmol/sample |